SPINOCEREBELLAR ATAXIAS
Clinical trials for SPINOCEREBELLAR ATAXIAS explained in plain language.
Never miss a new study
Get alerted when new SPINOCEREBELLAR ATAXIAS trials appear
Sign up with your email to follow new studies for SPINOCEREBELLAR ATAXIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug offered to rare neurological disorder patients
Disease control AVAILABLEThis program provides access to the investigational drug troriluzole for people with spinocerebellar ataxia (SCA), a rare genetic disorder that affects movement and coordination. The program is designed for patients who have a confirmed SCA diagnosis and may include both new pati…
Matched conditions: SPINOCEREBELLAR ATAXIAS
Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists gather genetic clues in hunt for ataxia cure
Knowledge-focused Recruiting nowThis study aims to build a large collection of genetic and health information from people with inherited ataxia diseases and their family members. Researchers will enroll 1000 participants, including patients, unaffected relatives, and healthy volunteers, to create a detailed res…
Matched conditions: SPINOCEREBELLAR ATAXIAS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:21 UTC